Business Segment Information (Tables)

12 Months Ended

Dec. 31, 2020

Business Segment Information

Schedule of operating results by business segment

					Corporate
			Pharmacy		and
	Healthcare		Management		Elimination		Consolidated
Year Ended December 31, 2018
Managed care and other revenue	$	2,110,756	$	240,427	$	(607)	$	2,350,576
PBM and dispensing revenue		—		2,625,417		(18,471)		2,606,946
Cost of care		(1,554,691)		—		—		(1,554,691)
Cost of goods sold		—		(2,468,170)		15,467		(2,452,703)
Direct service costs and other		(401,083)		(298,713)		(74,119)		(773,915)
Stock compensation expense (1)		6,446		5,458		17,032		28,936
Changes in fair value of contingent consideration (1)		1,108		—		—		1,108
Segment profit (loss)	$	162,536	$	104,419	$	(60,698)	$	206,257
Identifiable assets by business segment (2)
Restricted cash	$	52,681	$	576	$	2,954	$	56,211
Net accounts receivable		192,239		465,345		150		657,734
Investments		91,841		7,037		—		98,878
Pharmaceutical inventory		—		40,818		—		40,818
Goodwill		410,869		395,552		—		806,421
Other intangible assets, net		32,893		82,072		13,167		128,132

					Corporate
			Pharmacy		and
	Healthcare		Management		Elimination		Consolidated
Year Ended December 31, 2019
Managed care and other revenue	$	2,082,088	$	265,439	$	(592)	$	2,346,935
PBM revenue		—		2,236,829		(18,151)		2,218,678
Cost of care		(1,543,524)		—		—		(1,543,524)
Cost of goods sold		—		(2,076,509)		17,224		(2,059,285)
Direct service costs and other		(402,006)		(323,162)		(76,499)		(801,667)
Stock compensation expense (1)		7,639		7,834		9,200		24,673
Segment Profit (Loss)	$	144,197	$	110,431	$	(68,818)	$	185,810
Identifiable assets by business segment (2)
Restricted cash	$	49,027	$	2,226	$	—	$	51,253
Net accounts receivable		201,462		478,627		480		680,569
Investments		94,943		6,718		—		101,661
Pharmaceutical inventory		—		44,962		—		44,962
Goodwill		410,869		395,552		—		806,421
Other intangible assets, net		20,059		61,536		80		81,675

					Corporate
			Pharmacy		and
	Healthcare		Management		Elimination		Consolidated
Year Ended December 31, 2020
Managed care and other revenue	$	1,959,869	$	290,855	$	(703)	$	2,250,021
PBM revenue		—		2,347,446		(19,936)		2,327,510
Cost of care		(1,397,855)		—		—		(1,397,855)
Cost of goods sold		—		(2,199,674)		18,957		(2,180,717)
Direct service costs and other		(433,723)		(360,970)		(85,475)		(880,168)
Stock compensation expense (1)		6,876		7,723		10,573		25,172
Segment Profit (Loss)	$	135,167	$	85,380	$	(76,584)	$	143,963
Identifiable assets by business segment (2)
Restricted cash	$	33,381	$	12,658	$	3,188	$	49,227
Net accounts receivable		229,250		509,086		5,166		743,502
Investments		136,243		7,216		—		143,459
Pharmaceutical inventory		—		43,334		—		43,334
Goodwill		478,227		395,552		—		873,779
Other intangible assets, net		39,446		40,243		—		79,689

(1) Stock compensation expense, changes in the fair value of contingent consideration recorded in relation to the acquisitions and impairment of intangible assets are included in direct service costs and other operating expenses; however, these amounts are excluded from the computation of Segment Profit.

(2) Identifiable assets by business segment are those assets that are used in the operations of each segment. The remainder of the Company’s assets cannot be specifically identified by segment.

Schedule of reconciliation of Segment Profit to income before income taxes

	2018		2019		2020
Income (loss) from continuing operations before income taxes	$	33,633	$	21,759	$	(40,485)
Stock compensation expense		28,936		24,673		25,172
Changes in fair value of contingent consideration		1,108		—		—
Depreciation and amortization		112,284		110,367		98,387
Interest expense		35,180		35,868		30,865
Interest and other income		(4,884)		(6,857)		(4,054)
Special charges		—		—		34,078
Segment Profit from continuing operations	$	206,257	$	185,810	$	143,963